Real-time enrollment status for this achondroplasia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:42 AM UTC
| NCT Number | NCT07169279 |
| Recruiting Status | Recruiting |
| Condition | Achondroplasia |
| Phase | PHASE2 |
| Target Enrollment | 77 participants |
| Active Locations | 3 sites in the US |
| Sponsor | QED Therapeutics, Inc., a Bridgebio company |
| Last Updated on CT.gov | July 13, 2026 (5 days ago) |
As of July 18, 2026: Clinical trial NCT07169279 is currently recruiting participants. This phase2 study for achondroplasia is actively seeking new participants at 3 locations across the United States. The study is sponsored by QED Therapeutics, Inc., a Bridgebio company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07169279 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07169279 was last updated 5 days ago (July 13, 2026). HelloStudys verifies this status automatically.